查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853416

骶髂关节融合市场按产品类型、手术类型、最终用户、手术入路、固定机制和分销管道划分－2025-2032年全球预测

Sacroiliac Joint Fusion Market by Product Type, Procedure Type, End User, Approach, Fixation Mechanism, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，骶髂关节融合手术市场将成长至 19.1034 亿美元，复合年增长率为 12.12%。

关键市场统计数据
基准年 2024 7.6457亿美元
预计年份：2025年 8.5842亿美元
预测年份 2032 19.1034亿美元
复合年增长率 (%) 12.12%

骶髂关节融合术的现状以及在不断变化的医疗环境中开发能够影响患者治疗路径和医护人员决策的器械的临床必要性

随着临床医生寻求持久且创伤最小的解决方案来治疗难治性骶髂关节功能障碍患者，骶髂关节融合术已成为脊椎和骨盆治疗中日益重要的组成部分。随着诊断流程整合了先进的影像学检查、标靶注射和多学科评估，患者的选择变得更加明确，手术指征也更加清晰。同时，器械研发人员和手术专家致力于在考虑邻近解剖结构和长期融合生物学的同时，减少组织损伤并提高动态稳定性。

本导言概述了植入、器械、手术入路和医疗机构类型相互作用的临床环境。微创手术与成熟的开放性手术技术一样日益普及，侧入路和后入路等不同的入路方式具有不同的风险获益比，影响着外科医生的偏好和器械设计。同时，区分植入材料和固定机制需要在动态性能、影像相容性和外科医生熟悉程度之间取得平衡。随着医院、门诊手术中心和专科诊所适应不断变化的报销和支付模式，决策者在评估器械时，不仅会考虑临床结果，还会考虑器械与现有工作流程的整合、器械消毒方法和库存策略。

影像导引和导航技术的进步，加上不断迭代的植入设计，将继续完善骶髂关节融合术领域的患者治疗路径和应用动态。

新技术和护理模式的变革正在推动骶髂关节融合器材设计和临床应用模式的快速转变。

骶髂关节融合术领域正经历变革时期，主要得益于植入材料、术中导航和手术物流的创新。影像和导航技术的进步降低了许多医疗团队对透视成像的依赖，从而缩短了手术学习曲线，并提高了手术室的效率。导航辅助的微创技术能够实现更精准的植入，可望降低併发症发生率，并扩大适用患者范围。同时，植入几何形状和表面技术的改进，以及丰富的材料选择，使得设计者能够兼顾初始固定和长期癒合生物学特性。

在营运方面，门诊手术中心正采用简化的器械和精简的手术室，以支援高容量、低成本的医疗服务；而医院则优先处理复杂病例和改善术后恢復。分销模式也随之转变。与製造商和大型医疗系统建立直接合作关係，加速了客製化和服务整合；而分销商主导的管道对于覆盖更广泛的地域和小型医疗机构仍然至关重要。监管机构对手术编码和证据要求的澄清以及支付方的参与，也在影响产品开发的重点，并推动更高品质的临床数据和註册登记的参与。总而言之，这些转变正在重塑竞争动态，并为那些能够在临床结果、工作流程效率和总医疗成本方面展现清晰价值提案的参与企业创造机会。

评估2025年美国关税改革如何重塑相关人员的供应链采购重点、定价策略和营运韧性

一系列将于2025年在美国生效的关税调整，为医疗设备相关人员的采购和供应链策略带来了新的变数。从国际采购零件和成品的製造商正在重新审视其供应商布局，以减轻进口关税的影响，并加速了关于近岸外包和双重采购的讨论。这些调整正在影响前置作业时间和库存策略，迫使医院、门诊手术中心和专科诊所评估缓衝策略和合约弹性，以维持医疗服务的连续性。

采购团队正加强对到岸成本计算和总采购週期的审查，这改变了与直接製造商和经销商的谈判动态。对某些供应商而言，关税环境促使他们投资国内生产能力或采取关税工程策略来重新划分增值流程，而另一些供应商则选择自行承担关税，以维持价格竞争力并保有市场进入。实际上，这些策略性因应措施已经影响了工厂的资本规划，在临床疗效相当的情况下，可能会影响医疗器材的选择。

重要的是，关税实施时间表相关的政策不确定性凸显了适应性采购和情境规划的策略价值。那些在其供应链中提升透明度并优先考虑合约弹性的利益相关人员，将更有能力在贸易政策框架不断变化的情况下，保持对关键植入、器械和手术耗材的稳定供应。

基于细分市场的分析揭示了不同产品类型、操作方式、最终用户方法、客户维繫机制和分销管道的不同需求讯号

从细分角度来看，该领域在产品、手术流程、最终用户、手术方法、固定机制和分销管道等方面的需求模式和发展重点存在差异。按产品类型划分，该领域可分为植入和器械，其中植入尤其註重材料选择。在植入领域，PEEK笼状结构与钛笼状结构展开竞争，两者在放射学和动态方面各有优劣，影响着外科医师的偏好。按手术类型划分，该领域涵盖微创手术和开放性手术。微创手术的差异化体现在透视引导流程和导航辅助平台等方面，而开放性手术则通常依赖手工技术和既定的暴露策略。

终端使用者细分突显了门诊手术中心、医院和专科诊所在营运方面的权衡取舍。侧位、后位和后外侧入路的区分决定了植入几何形状和器械轨迹，以应对独特的解剖结构和手术入路限制。固定机制细分突出了椎间融合器、钢板固定、钢棒固定和螺钉固定等选项，这些选项的选择取决于所需的稳定性、融合策略和外科医生的操作舒适度。最后，直销和分销销售管道细分影响商业性合作模式、售后支援预期以及产品在不同地区的供应情况。整合这些细分维度，可以为产品开发、临床证据产生和市场推广策略的优先排序提供一个结构化的框架，从而满足各个相关人员的需求。

影响技术采纳率的区域动态和病患人口统计资料；全球各区域的报销途径；临床基础设施和商业化策略

区域动态对美洲、欧洲、中东和非洲以及亚太地区的采纳选择、监管重点和商业化路径有显着影响。在美洲，成熟的临床路径和众多先进的脊椎中心促进了微创技术和先进植入的快速普及，而医院网路结构和门诊手术中心的成长则影响着采购週期和采购谈判。在欧洲、中东和非洲地区，不同的法律规范和报销系统造成了实施时间表的差异。一些市场倾向于集中采购和成本效益分析，而另一些市场则优先考虑透过私人医院系统快速获得新型设备。

在亚太地区，患者数量庞大、手术能力不断提升以及本地製造能力的增强，共同推动了市场需求，并加剧了价格竞争压力。在全部区域，影像基础设施、外科医师训练模式和医疗机构的运作效率存在差异，进而影响着对特定手术方法和固定机制的偏好。此外，跨区域伙伴关係、监管协调以及策略性製造投资正在改变企业拓展销售管道和支援临床培训的方式，进而影响各地区的长期商业性生存能力。

竞争格局洞察突显了设备製造商和服务供应商之间的策略性倡议、产品创新伙伴关係、市场策略和能力差距。

骶髂关节融合领域的企业策略主要围绕着三个关键主题：差异化的临床价值、一体化的服务产品以及营运扩充性。各企业强调可靠的临床证据和明确的手术优势，并将研发重点放在优化植入设计和器械人体工学上，以缩短手术时间并降低併发症发生率。另一些企业则致力于开发整合系统，将导航、植入和服务合约捆绑在一起，以降低手术团队和医疗机构的采用门槛。设备开发商与影像和导航技术提供者之间的策略伙伴关係已成为打造涵盖整个手术流程的综合解决方案的有效途径，而非仅仅提供单一产品。

在商业性，一些公司优先考虑与大型医疗系统进行直接客户管理，以获取长期处方和临床整合的机会；而另一些公司则利用分销商网络来涵盖更多医院和专科诊所。随着支付方和市场参与企业期望获得长期疗效数据，上市后监测、註册登记参与和真实世界证据收集正日益成为重要的差异化因素。此外，设备生命週期支援方面仍然存在能力缺口，尤其是在培训、设备维护和物流方面，这为能够提供全面服务模式、减少客户营运摩擦的公司提供了机会。

为产业领导者提供切实可行的策略建议，以加强其产品组合、优化营运、加速产品推广，并因应政策和供应链的不利因素。

产业领导者应采取一系列协调一致的行动，以平衡临床差异化、供应链韧性和市场进入有效性。首先，应优先投资于高品质的比较临床证据，并建立符合支付方要求和外科医生标准的註册登记系统，以便更好地展示手术在不同患者群体中的效用。同时，应优化植入产品组合，重点关注模组化和互通性，以降低医院和门诊中心的库存复杂性，并加速新材料和固定方法的应用。

在营运方面，我们将制定灵活的筹资策略，结合区域製造、双供应商模式和库存优化，以降低关税和运输成本波动的影响。我们将透过直销管道为大型医疗系统提供客製化的服务包，同时利用经销商合作伙伴关係，为小型医疗机构提供地理伙伴关係，从而强化我们的商业模式。我们将投资于外科医生培训计画和数位化教育平台，以缩短导航辅助和微创手术的学习曲线。最后，我们将整合设备维护、数据分析和结果支援等生命週期服务，以深化客户关係，并创造稳定的经常性收入来源，从而实现长期成长。

调查方法和资料来源 资料来源和访谈框架 分析方法 透明的调查方法，概述了检验方案和局限性，确保了可靠的证据综合。

本研究方法系统性地整合了同侪审查的临床文献、监管文件、操作指南和相关人员访谈，以建立可靠的依证。主要资料收集包括对来自不同实践领域的临床医生、供应链和采购负责人以及器械商业化专家进行访谈，以了解实际操作中的考虑因素和推广应用的驱动因素。次要研究则纳入了器械标籤、临床试验註册资讯和技术白皮书，以检验临床性能属性和器械特性。

分析步骤将临床结果与手术方法和器械属性进行交叉比对，以识别细分维度上的契合点和差距。定性见解与供应链和政策分析相结合，以评估贸易和采购动态的实际影响。检验过程包括与部分受访者进行后续访谈以及外部专家评审，以确保解释的一致性。调查方法和资料来源的限制包括不同地区资料可用性的差异以及器械核准和手术报销途径的不断变化。这些限制透过强调多个独立资讯来源支持的趋势并清楚记录細項分析的基本假设来加以缓解。

一份简洁的结论，综合了临床、商业性和政策方面的影响，并概述了相关人员将洞见转化为策略行动的优先事项。

摘要：骶髂关节融合术正处于曲折点，器械创新、技术改进和供应链动态正在重塑临床和商业策略。临床方面，影像和导航技术的进步，以及材料和固定方法的创新，扩大了微创技术的安全应用范围，同时在适当情况下保留了开放性手术的选择。商业性，产品类型、手术方式、医疗机构环境、手术入路、固定机制和分销管道等方面的细分，需要製定细緻的市场推广计划，使产品能够适应医院、门诊手术中心和专科诊所的实际情况。

政策和贸易发展凸显了建构具有韧性和适应性的采购模式的必要性。拥有令人信服的临床证据、精简的设备和全面的生命週期服务的公司将更有利于获得长期的临床应用和机构伙伴关係。对于整个生态系统的相关人员而言，重点应放在透过培训、整合工作流程以及与支付方和医疗服务提供者开展基于价值的对话，将循证医学转化为实践，以确保患者获得治疗和手术的永续性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 人们越来越倾向于选择三角形钛合金植入，这种植入物旨在增强旋转稳定性。
  • 术中CT和透视技术的融合应用日益广泛，以实现植入即时定位。
  • 开发3D列印多孔金属植入以促进加速骨整合
  • 扩大报销代码范围，以支持门诊手术中心的门诊护理
  • 外科医生培训计画的激增，主要集中在机器人辅助经皮体外手术技术。
  • 越来越多的临床证据表明，后路骶髂关节固定术能够持续缓解疼痛。
  • 生物活性涂层在植入的进展可降低术后感染率
  • 利用人工智慧驱动的解剖建模技术，开发出针对特定患者的植入规划软体。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 骶髂关节融合手术市场（依产品类型划分）

  • 植入
    • PEEK笼
    • 钛笼
  • 装置

9. 骶髂关节融合手术市场（依手术类型划分）

  • 微创
    • 透视指南
    • 导航辅助
  • 开放性手术
    • 手工技术

第十章 骶髂关节融合手术市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十一章 骶髂关节融合手术市场（依手术入路划分）

  • 水平的
  • 后端
  • 后外侧

12. 依固定机转分類的骶髂关节融合手术市场

  • 椎间装置
  • 钢板固定
  • 桿固定
  • 螺丝固定

第十三章 骶髂关节融合手术市场（依通路划分）

  • 直销
  • 批发商

第十四章 骶髂关节融合手术市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 骶髂关节融合手术市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国骶髂关节融合手术市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • SI-BONE, Inc.
    • DePuy Synthes, Inc.
    • Medtronic plc
    • Stryker Corporation
    • Globus Medical, Inc.
    • Orthofix Medical Inc.
    • SeaSpine Holdings Corporation
    • NuVasive, Inc.
    • Alphatec Spine, Inc.
    • RTI Surgical, Inc.
Product Code: MRR-3A2E844FDC50

The Sacroiliac Joint Fusion Market is projected to grow by USD 1,910.34 million at a CAGR of 12.12% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 764.57 million
Estimated Year [2025] USD 858.42 million
Forecast Year [2032] USD 1,910.34 million
CAGR (%) 12.12%

Sacroiliac joint fusion landscape and clinical imperatives shaping device development patient pathways and provider decision-making in an evolving care environment

Sacroiliac joint fusion occupies an increasingly prominent place within the spine and pelvic care continuum as clinicians seek durable, minimally disruptive solutions for patients with refractory sacroiliac joint dysfunction. Patient selection has sharpened as diagnostic pathways integrate advanced imaging, targeted injections, and multidisciplinary evaluation, resulting in clearer indications for procedural intervention. Concurrently, device developers and proceduralists have focused on reducing tissue disruption and improving biomechanical stability while accounting for adjacent anatomy and long-term fusion biology.

This introduction frames the clinical landscape in which implants, instruments, procedural approaches, and facility types interact. Minimally invasive pathways are gaining traction alongside established open techniques, and approaches such as lateral and posterior access each offer distinct risk-benefit profiles that inform surgeon preference and device design. Meanwhile, differentiation between implant materials and fixation mechanisms reflects a balance of biomechanical performance, imaging compatibility, and surgeon familiarity. As hospitals, ambulatory surgical centers, and specialty clinics adapt to evolving reimbursement and care delivery models, decision-makers will increasingly evaluate devices not only on clinical outcomes but on integration into existing workflows, instrument sterilization practices, and inventory strategies.

Taken together, advancements in imaging guidance and navigation, coupled with iterative implant design, set the stage for continued refinement of patient pathways and adoption dynamics in the sacroiliac fusion arena.

Emerging technologies and care model disruptions driving rapid shifts in sacroiliac joint fusion procedures device design and clinical adoption patterns

The sacroiliac fusion landscape is undergoing transformative shifts driven by innovation in implant materials, intraoperative guidance, and procedural logistics. Advances in imaging and navigation have reduced dependence on fluoroscopic exposure for many teams, which in turn influences the procedural learning curve and operating room throughput. Navigation-assisted minimally invasive techniques enable more precise implant placement, potentially lowering complication rates and broadening the pool of patients eligible for intervention. At the same time, improvements in implant geometry and surface technology-coupled with expanded material choices-have encouraged designers to optimize for both initial fixation and long-term fusion biology.

Operationally, ambulatory surgical centers have embraced simplified instrumentation and streamlined procedural sets to support high-volume, low-cost delivery of care, while hospitals maintain a focus on complex cases and post-acute pathways. Distribution models have adapted accordingly: direct relationships between manufacturers and high-volume systems accelerate customization and service integration, whereas distributor-led channels remain critical for broad geographic reach and smaller facilities. Regulatory clarity and payer engagement around procedural coding and evidence requirements are also shaping product development priorities, incentivizing higher-quality clinical data and registry participation. Collectively, these shifts are recalibrating competitive dynamics and creating opportunities for entrants that can demonstrate clear value propositions across clinical outcomes, workflow efficiency, and total cost of care.

Assessment of how United States tariff changes in 2025 are reshaping supply chains procurement priorities pricing strategies and operational resilience across stakeholders

The suite of tariff changes enacted in the United States in 2025 has introduced new variables into procurement and supply chain strategies for medical device stakeholders. Manufacturers that source components or finished goods internationally have revisited supplier footprints to mitigate inbound duty exposure, accelerating conversations around nearshoring and dual-sourcing. These adjustments have implications for lead times and inventory policies, prompting hospitals, ambulatory surgical centers, and specialty clinics to evaluate buffer strategies and contractual flexibility to maintain continuity of care.

Procurement teams have increased scrutiny on landed cost calculations and total procurement cycle time, which has shifted negotiation dynamics with both direct manufacturers and distributors. For some suppliers, the tariff environment has catalyzed investments in domestic manufacturing capacity or in tariff engineering approaches to reclassify value-added processes, while others have absorbed duties to preserve competitive pricing and maintain market access. In practice, these strategic responses affect capital planning for facilities and can influence device selection where comparable clinical outcomes exist.

Importantly, policy uncertainty associated with tariff implementation timelines has elevated the strategic value of adaptive sourcing and scenario planning. Stakeholders that foster transparency across the supply chain and prioritize contractual resilience are positioning themselves to maintain stable access to critical implants, instruments, and procedural consumables despite evolving trade policy frameworks.

Segment-focused analysis revealing differentiated demand signals across product types procedure modalities end users approaches fixation mechanisms and distribution channels

A segmentation-focused lens reveals differentiated demand patterns and development priorities across product, procedure, end user, approach, fixation mechanism, and distribution dimensions. Based on product type, the field separates implants from instruments, with implants drawing particular attention to material choice; within implants, PEEK cage designs compete against titanium cage constructs, each offering distinct radiographic and biomechanical considerations that influence surgeon preference. Based on procedure type, the spectrum ranges from minimally invasive to open surgery modalities; minimally invasive options are further distinguished by fluoroscopy-guided workflows and navigation-assisted platforms, while open surgery pathways frequently rely on manual technique and established exposure strategies.

End user segmentation underscores the operational trade-offs among ambulatory surgical centers, hospitals, and specialty clinics, as each setting dictates different throughput, sterilization, and inventory constraints that affect product selection. Approach differentiation across lateral, posterior, and posterior lateral corridors drives implant geometry and instrumentation pathways to address unique anatomic vectors and access limitations. Fixation mechanism segmentation spotlights interbody devices, plate fixation, rod fixation, and screw fixation alternatives, which are chosen based on desired stability, fusion strategy, and surgeon comfort. Finally, distribution channel segmentation between direct and distributor routes shapes commercial engagement models, post-market support expectations, and product availability in diverse geographies. Synthesizing these segmentation axes provides a structured framework for prioritizing product development, clinical evidence generation, and go-to-market tactics tailored to distinct stakeholder needs.

Regional dynamics and patient demographics influencing adoption rates reimbursement pathways clinical infrastructure and commercialization strategies across global regions

Regional dynamics materially influence adoption choices, regulatory priorities, and commercialization pathways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established clinical pathways and a high concentration of advanced spine centers support rapid diffusion of minimally invasive techniques and advanced implants, while the structure of hospital networks and ambulatory surgical center growth shapes procurement cycles and purchasing negotiations. Moving to Europe, the Middle East & Africa corridor, heterogeneous regulatory frameworks and reimbursement systems create diverse adoption timelines; some markets favor centralized procurement and cost-effectiveness analyses, whereas others prioritize rapid access to novel devices through private hospital systems.

In the Asia-Pacific region, a combination of large patient volumes, expanding surgical capacity, and increasing local manufacturing capability fosters both demand and competitive pricing pressure. Across these regions, differences in imaging infrastructure, surgeon training models, and facility throughput drive preference for specific approaches and fixation mechanisms. Furthermore, cross-regional partnerships, regulatory harmonization efforts, and strategic manufacturing investments are shifting how companies deploy distribution channels and support clinical training, thereby shaping long-term commercial viability in each geography.

Competitive landscape insights highlighting strategic moves product innovation partnerships go-to-market approaches and capability gaps among device manufacturers and service providers

Company strategies in the sacroiliac fusion space have coalesced around three principal themes: differentiated clinical value, integrated service offerings, and operational scalability. Competitors that emphasize robust clinical evidence and clear procedural advantages have focused R&D on implant design optimization and instrumentation ergonomics to shorten operative time and reduce complication profiles. Others have pursued integrated systems that bundle navigation, implants, and service agreements to lower the barrier for adoption among surgical teams and facilities. Strategic partnerships between device developers and imaging or navigation technology providers have emerged as an effective route to create cohesive offerings that address a full procedural workflow rather than single-point products.

Commercially, some firms prioritize direct account management for large health systems to capture long-term formularies and clinical integration opportunities, while alternative players leverage distributor networks to reach a wider set of hospitals and specialty clinics. Post-market surveillance, registry participation, and real-world evidence collection are increasingly important differentiators, as payers and providers expect longitudinal outcomes data. Additionally, capability gaps remain in lifecycle support for devices-especially in training, instrument maintenance, and logistics-which opens opportunities for companies that can deliver comprehensive service models that reduce operational friction for customers.

Actionable strategic recommendations for industry leaders to strengthen portfolios optimize operations accelerate adoption and navigate policy and supply chain headwinds

Industry leaders should pursue a set of coordinated actions that balance clinical differentiation, supply chain resilience, and market access effectiveness. First, prioritize investment in high-quality comparative clinical evidence and registries that align with payer requirements and surgeon decision criteria, enabling clearer demonstrations of procedural benefit across patient cohorts. Simultaneously, optimize implant portfolios by focusing on modularity and cross-compatibility to reduce inventory complexity for hospitals and ambulatory centers while accelerating adoption of newer materials and fixation options.

From an operational perspective, develop flexible sourcing strategies that combine regional manufacturing, dual suppliers, and inventory optimization to mitigate tariff and transport volatility. Strengthen commercial models by offering tailored service bundles for large health systems through direct channels while leveraging distributor partnerships to maintain geographic coverage in smaller facilities. Invest in surgeon training programs and digital education platforms to shorten the learning curve for navigation-assisted and minimally invasive techniques, and align reimbursement teams early to shape coding and payment pathways. Finally, incorporate lifecycle service offerings-instrument maintenance, data analytics, and outcomes support-to deepen customer relationships and create recurring revenue streams that stabilize long-term growth.

Transparent research methodology outlining data sources interview frameworks analytical approaches validation protocols and limitations ensuring robust evidence synthesis

The research approach combined a structured synthesis of peer-reviewed clinical literature, regulatory documents, procedural guidance, and stakeholder interviews to produce a robust evidence base. Primary data collection included interviews with clinicians across diverse practice settings, supply chain and procurement leaders, and device commercialization experts to capture real-world operational considerations and adoption drivers. Secondary research incorporated device labeling, clinical trial registries, and technical white papers to validate clinical performance attributes and device characteristics.

Analytical steps involved cross-referencing clinical outcomes with procedural approaches and device attributes to identify alignment and gaps across segmentation axes. Qualitative insights were triangulated with supply chain and policy analyses to assess the practical implications of trade and procurement dynamics. Validation processes included follow-up conversations with selected respondents and external expert review to ensure interpretive coherence. Limitations of the methodology include variation in regional data availability and the evolving nature of device approvals and procedural reimbursement pathways; these were mitigated by emphasizing trends supported by multiple independent sources and explicit documentation of assumptions underlying segmentation analyses.

Concise conclusion synthesizing clinical, commercial, and policy implications and outlining priorities for stakeholders to translate insights into strategic action

In summary, sacroiliac joint fusion is at an inflection point where device innovation, procedural refinement, and supply chain dynamics are collectively reshaping clinical practice and commercial strategies. Clinically, advances in imaging and navigation coupled with material and fixation innovations are expanding the safe application of minimally invasive techniques while preserving options for open surgery where appropriate. Commercially, segmentation across product types, procedural modalities, facility settings, approaches, fixation mechanisms, and distribution channels requires nuanced go-to-market planning that aligns product design with the operational realities of hospitals, ambulatory surgical centers, and specialty clinics.

Policy and trade developments have underscored the need for resilient sourcing and adaptable procurement models. Companies that combine compelling clinical evidence, streamlined instrumentation, and comprehensive lifecycle services will be best positioned to capture long-term clinical adoption and institutional partnerships. For stakeholders across the ecosystem, the emphasis should be on translating evidence into practice through training, integrated workflows, and value-based conversations with payers and providers to ensure patient access and procedural sustainability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising preference for triangular titanium implants designed for enhanced rotational stability
  • 5.2. Growing integration of intraoperative CT and fluoroscopy for real time implant positioning
  • 5.3. Development of 3D printed porous metal implants to promote accelerated osseointegration
  • 5.4. Expansion of reimbursement codes supporting outpatient sacroiliac joint fusion procedures under ambulatory surgery centers
  • 5.5. Surge in surgeon training programs focused on percutaneous lateral sacroiliac joint fusion techniques with robotics assistance
  • 5.6. Increasing clinical evidence demonstrating sustained pain relief from posterior sacroiliac fusion approaches
  • 5.7. Advancements in bioactive coatings for implants aimed at reducing post procedural infection rates
  • 5.8. Emergence of patient specific implant planning software leveraging AI driven anatomical modeling

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sacroiliac Joint Fusion Market, by Product Type

  • 8.1. Implants
    • 8.1.1. PEEK Cage
    • 8.1.2. Titanium Cage
  • 8.2. Instruments

9. Sacroiliac Joint Fusion Market, by Procedure Type

  • 9.1. Minimally Invasive
    • 9.1.1. Fluoroscopy Guided
    • 9.1.2. Navigation Assisted
  • 9.2. Open Surgery
    • 9.2.1. Manual Technique

10. Sacroiliac Joint Fusion Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Sacroiliac Joint Fusion Market, by Approach

  • 11.1. Lateral
  • 11.2. Posterior
  • 11.3. Posterior Lateral

12. Sacroiliac Joint Fusion Market, by Fixation Mechanism

  • 12.1. Interbody Devices
  • 12.2. Plate Fixation
  • 12.3. Rod Fixation
  • 12.4. Screw Fixation

13. Sacroiliac Joint Fusion Market, by Distribution Channel

  • 13.1. Direct
  • 13.2. Distributor

14. Sacroiliac Joint Fusion Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Sacroiliac Joint Fusion Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Sacroiliac Joint Fusion Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. SI-BONE, Inc.
    • 17.3.2. DePuy Synthes, Inc.
    • 17.3.3. Medtronic plc
    • 17.3.4. Stryker Corporation
    • 17.3.5. Globus Medical, Inc.
    • 17.3.6. Orthofix Medical Inc.
    • 17.3.7. SeaSpine Holdings Corporation
    • 17.3.8. NuVasive, Inc.
    • 17.3.9. Alphatec Spine, Inc.
    • 17.3.10. RTI Surgical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. SACROILIAC JOINT FUSION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. SACROILIAC JOINT FUSION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SACROILIAC JOINT FUSION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PEEK CAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PEEK CAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PEEK CAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PEEK CAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PEEK CAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PEEK CAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY TITANIUM CAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY TITANIUM CAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY TITANIUM CAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY TITANIUM CAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY TITANIUM CAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY TITANIUM CAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FLUOROSCOPY GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FLUOROSCOPY GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FLUOROSCOPY GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FLUOROSCOPY GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FLUOROSCOPY GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FLUOROSCOPY GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY NAVIGATION ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY NAVIGATION ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY NAVIGATION ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY NAVIGATION ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY NAVIGATION ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY NAVIGATION ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MANUAL TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MANUAL TECHNIQUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MANUAL TECHNIQUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MANUAL TECHNIQUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MANUAL TECHNIQUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY MANUAL TECHNIQUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY LATERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY LATERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY LATERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY LATERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY LATERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY LATERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR LATERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR LATERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR LATERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR LATERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR LATERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY POSTERIOR LATERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INTERBODY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INTERBODY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INTERBODY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INTERBODY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INTERBODY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY INTERBODY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PLATE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PLATE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PLATE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PLATE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PLATE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY PLATE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY ROD FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY ROD FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY ROD FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY ROD FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY ROD FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY ROD FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SCREW FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SCREW FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SCREW FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SCREW FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SCREW FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY SCREW FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY OPEN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY APPROACH, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY FIXATION MECHANISM, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC SACROILIAC JOINT FUSION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL SACROILIAC JOINT FUSION MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN SACROILIAC JOINT FUSION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. ASE